Parx Materials Parx Materials

EU and US food contact compliance.

Zwiers Regulatory Consultancy finalised its evaluation of the compliance of Saniconcentrate™ in food contact applications according to EU and US regulations.

Read More
Parx Materials Parx Materials

Covid-19 mask eliminates 98% of Influenza-A virus in 2 hours.

Now SGS also confirmed that the material has antiviral properties against Influenza-A virus H3N and reduces this virus by 98.06% in 2 hours following the ISO 18184:2014 testing protocol. This is on top of to the proven efficacy against: Corona 229E virus and H1N1 virus.

Read More
Parx Materials Parx Materials

Permanent medical implant safety compliance confirmed.

Zwiers Regulatory Consultancy finalized its evaluation of the safety of the Parx Materials technology in medical devices according to the applicable standards (ISO 10993) and Regulation (EC) No 1907/2006. The outcome was that the starting and reaction materials applied are well-known and can be used to further process as part of a medical device.

Read More
Parx Materials Parx Materials

Bio-designed anti-odor technology also resolving skin condition.

Current anti-odor technologies are using migrating technologies, having a biocide leach out of the garment to kill odor-causing bacteria. These solutions wash out in the washing machine and contaminate our oceans and environment. The Parx technology is biocompatible and does not wash out and improvement of medical skin conditions are reported by users.

Read More
Parx Materials Parx Materials

EU certification for Parx Covid-19 filtering half mask.

Parx Materials NV announces the official EU certification for a filtering half mask to protect against Covid-19 made with the addition of Saniconcentrate. The Danish EU-notified body verified that the product is in accordance with the recommended use No. PPE-R/0.2/075 and Regulation (EU) 2016/425 of the EU.

Read More
Parx Materials Parx Materials

Parx technology effective against multiple viruses.

BREAKING NEWS: Independent tests show that Parx Materials technology is highly effective against viruses. Tests performed following ISO protocols to identify antiviral properties on solid plastic surfaces and textiles show a significant effect against the Human Corona 229E and H1N1 virus.

Read More
Parx Materials Parx Materials

Resolving biofouling in marine aquaculture and increasing yield.

Aquaculture tanks produced using Saniconcentrate™ are still clean and without fouling after 6 months in the ocean. Plus they house significantly better developed, larger Abalones than the normal tanks. This means more yield of this valuable delicacy and more profit for the aquaculture farm.

Read More
Parx Materials Parx Materials

Orthopaedic patent granted in EU

Parx Plastics NV (Euronext: MLPRX) is pleased to report that our EU patent application for the use of the company’s technologies in polymer parts of orthopaedic implants (e.g. hip and knee joints) has been granted. Earlier this year the patent was already granted in the territory of Italy and the extension into the rest of the EU is now successfully completed.

Read More